Latest Breaking News On - Granules pharmaceuticals inc - Page 15 : comparemela.com

Granules India Limited announces approval of Potassium Chloride ER Capsules USP, generic equivalent of Micro-K ER Capsules of Nesher Pharmaceuticals (USA) LLC

Granules India Limited announces approval of Potassium Chloride ER Capsules USP, generic equivalent of Micro-K ER Capsules of Nesher Pharmaceuticals (USA) LLC
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshPriyanka chigurupatiNesher pharmaceuticals united statesEr capsules of nesher pharmaceuticals united statesGranules pharmaceuticals incGranules indiaUs food drug administrationIndia limitedPotassium chlorideNesher pharmaceuticalsTime zoneDrug administrationAbbreviated new drug applicationPotassium chloride extended release capsulesMicrok extended release capsules

How second-generation entrepreneur Priyanka Chigurupati is taking her family s pharma business forward

How second-generation entrepreneur Priyanka Chigurupati is taking her family’s pharma business forward A second-generation entrepreneur, Priyanka Chigurupati started her career with pharma company Granules India as a marketing manager for a region-specific division and soon moved to head a new API facility and establish the US team for Granules Inc. 0 claps Share on Priyanka Chigurupati says she didn’t have the slightest inkling of what she would be doing before she joined Granules, the family business. After graduating in bachelor’s of science in business management from Case Western Reserve University in Cleveland, Ohio, she took her interest in fashion forward by pursuing an associate degree in applied science (fashion marketing) at Parsons, the New School of Design.

Andhra pradeshUnited statesAyers rockNorthern territoryPriyanka chigurupatiKrishna prasad chigurupatiIndia ltdGranules pharmaceuticalsGranules pharmaceuticals incCase western reserve university in clevelandSchool of designCase western reserve universityNew schoolKrishna prasadGranules indiaActive pharmaceutical ingredients

Global Ranitidine (Zantac) Market 2020 Industry Analysis by Key Players, Product Type, Application, Regions and Forecast to 2025

Global Ranitidine (Zantac) Market 2020 Industry Analysis by Key Players, Product Type, Application, Regions and Forecast to 2025
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

United kingdomSaudi arabiaSun pharmaRanitidine zantacCare pharmaceuticalsSandoz incGlenmark pharmaceuticalsTeva pharmaceuticalsTech pharmacal coApotex corporationLaboratories incHikma pharmaceuticalsResearch newswireGranules pharmaceuticals incApotex incMylan pharmaceuticals inc

Granules India receives USFDA approval for Potassium Chloride Oral Solution

Granules India announced today that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI)., a wholly owned foreign subsidiary of Granules India, for Potassium Chloride Oral Solution USP, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%). It is bioequivalent to the reference listed drug product (RLD), Potassium Chloride Oral Solution, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%), of Genus Lifesciences, Inc. The product would be available in bottle of 473 ml and is expected to be launched shortly. Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose

Granules pharmaceuticals incUs food drug administrationGenus lifesciences incGranules indiaDrug administrationAbbreviated new drug applicationGranules pharmaceuticalsPotassium chloride oral solutionGenus lifesciencesChloride oralCapital marketPhysical sciencesChemical elementsDietary mineralsElectrolyte disturbancesMetal halides

Granules India gets USFDA nod for generic potassium chloride oral solution

The US drug regulator has approved the ANDA filed by Granules Pharmaceuticals, Inc, a wholly owned foreign arm of Granules India, for potassium chloride oral solution USP, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%). The product is bio-equivalent to the reference listed drug product (RLD), potassium chloride oral solution, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%), of Genus Lifesciences, Inc. The product would be available in bottle of 473 ml and is expected to be launched shortly. Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. Granules now has a total of 36 ANDA approvals from USFDA (35 final approvals and 1 tentative approvals).

Granules pharmaceuticals incGenus lifesciences incGranules pharmaceuticalsGranules indiaGenus lifesciencesFinished dosagesPharmaceutical formulation intermediatesActive pharmaceutical ingredientsCapital marketPotassium chlorideGranules india limitedElectrolyte disturbancesMedical specialtiesPhysical sciencesMetabolic alkalosisPotassium chloride oral solution